ArticleTherapeutic advances in medical oncology2022

Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer.

Valentina Hoyos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.